一例X-连锁无丙种球蛋白血症患者BTK基因新变异体的鉴定

基础医学与临床 ›› 2021, Vol. 41 ›› Issue (4): 467-471.

• 研究论文 • 下一篇

一例X-连锁无丙种球蛋白血症患者BTK基因新变异体的鉴定

张晗¹, 孙阳¹, 王蓉蓉¹, 张文^2*, 张学^1*

1.中国医学科学院基础医学研究所北京协和医学院基础学院麦库西克-张孝骞协和遗传医学中心医学分子生物学国家重点实验室,北京 100005;
2.中国医学科学院北京协和医学院北京协和医院风湿免疫科国家皮肤与免疫临床医学中心卫生部重点实验室,北京 100730

收稿日期:2020-12-17 修回日期:2021-01-12 出版日期:2021-04-05 发布日期:2021-04-05
通讯作者: ^*xuezhang@pumc.edu.cn;zhangwen91@sina.com
基金资助:
国家重点研发计划项目(2016YFC0905100);国家自然科学基金(81788101);中国医学科学院医学与健康科技创新工程项目(2016-I2M-1-002&2017-I2M-3-001)

Identification of a novel BTK variant in a Chinese family with X-linked agammaglobulinemia

ZHANG Han¹, SUN Yang¹, WANG Rong-rong¹, ZHANG Wen^2*, ZHANG Xue^1*

1. McKusick-Zhang Center for Genetic Medicine, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences CAMS, School of Basic Medicine PCMC, Beijing 100005;
2. Department of Rheumatology, National Clinical Research Center for Dermatologic and Immunologic Diseases(NCRC-DID), Key Laboratory of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College,Beijing 100730, China

Received:2020-12-17 Revised:2021-01-12 Online:2021-04-05 Published:2021-04-05
Contact: ^*xuezhang@pumc.edu.cn;zhangwen91@sina.com

摘要/Abstract

摘要： 目的对一例X-连锁无丙种球蛋白血症(XLA)患者进行致病基因变异鉴定。方法收集患者及家庭成员临床资料并采集外周血,从患者外周血中提取基因组DNA并进行全外显子组测序,筛查可疑致病变异,并对其父母基因组DNA进行Sanger测序验证及基因型-表型共分离分析,从患者外周血中提取RNA,反转录为cDNA后进行Sanger测序,同时进行实时定量PCR实验检测该基因表达水平,进而对该变异的致病性和致病机制进行分析。结果患者携带BTK基因c.240+3A＞C新变异,该变异遗传自母亲,在家系中呈基因型-表型共分离,该变异体在dbSNP153、ExAC、gnomAD和HGMD等公共数据库未见报道。该变异属于剪接变异,cDNA测序显示该变异造成BTK基因3号内含子5′端106 bp碱基插入到第3号和第4号外显子之间,引起阅读框改变,最终导致终止密码子提前出现。患者BTK基因mRNA表达水平明显降低。结论 BTK基因c.240+3A＞C处剪接变异可能导致该患者患X-连锁无丙种球蛋白血症。

关键词: X-连锁无丙种球蛋白血症, 全外显子组测序技术, BTK基因, 致病变异

Abstract: Objective To identify the pathogenic variant in a Chinese family with X-linked agammaglobulinemia (XLA). Methods A trio family with suspected X-linked agammaglobulinemia was recruited. The pathogenic variant was detected by the whole exome sequencing, and then confirmed by Sanger sequencing. cDNA sequencing was performed to find the abnormal splicing of the BTK variant. Quantitative real-time PCR was conducted to evaluate the mRNA expression of BTK in the patient. Results A novel hemizygous splicing variant (c.240+3A＞C) was identified in the BTK gene from this patient. The variant co-segregated with the phenotype of the family members was not listed in the public databases, such as dbSNP153,ExAC, gnomAD or the Human Gene Mutation Database. Further Sanger sequencing demonstrated that the BTK c.240+3A＞C variant led to a 106 bp from intron 3 of BTK insertion between exon 3 and exon 4 of the BTK transcript. The mRNA expression of BTK in the patient was significantly reduced as compared to a control individual. Conclusions The novel c.240+3A＞C splicing variant in BTK likely results in X-linked agammaglobulinemia in this family.

Key words: X-linked agammaglobulinemia, whole exome sequencing, BTK, pathogenic variant

中图分类号:

R596.2

张晗, 孙阳, 王蓉蓉, 张文, 张学. 一例X-连锁无丙种球蛋白血症患者BTK基因新变异体的鉴定[J]. 基础医学与临床, 2021, 41(4): 467-471.

ZHANG Han, SUN Yang, WANG Rong-rong, ZHANG Wen, ZHANG Xue. Identification of a novel BTK variant in a Chinese family with X-linked agammaglobulinemia[J]. Basic & Clinical Medicine, 2021, 41(4): 467-471.

参考文献

[1] Bruton OC. Agammaglobulinemia[J]. Pediatrics, 1952,9: 722-728.
[2] Degand N, Dautremer J, Pilmis B, et al. Helicobacter bilis-associated suppurative cholangitis in a patient with X-linked agammaglobulinemia[J]. J Clin Immunol, 2017,37: 727-731.
[3] Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients[J]. Medicine (Baltimore), 2006,85: 193-202.
[4] Conley ME, Dobbs AK, Farmer DM, et al. Primary B cell immunodeficiencies: comparisons and contrasts[J]. Annu Rev Immunol, 2009,27: 199-227.
[5] Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases[J]. Nature, 1993,361: 226-233.
[6] 张抒扬. 罕见病诊疗指南[M]. 北京: 人民卫生出版社, 2019: 625-629.
[7] Nomura K, Kanegane H, Karasuyama H, et al. Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway[J]. Blood, 2000,96: 610-617.
[8] Fekrvand S, Yazdani R, Olbrich P, et al. Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia[J]. Pediatr Allergy Immunol, 2020,31: 405-417.
[9] Aadam Z, Kechout N, Barakat A, et al. X-linked agammaglobulinemia in a large series of north african patients: frequency, clinical features and novel BTK mutations[J]. J Clin Immunol, 2016,36: 187-194.
[10] Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the Src family of protein-tyrosine kinases. 1993[J]. J Immunol, 2012,188: 2948-2955.
[11] 张抒扬, 赵玉沛. 罕见病学[M]. 北京: 人民卫生出版社, 2020: 354-356.
[12] Lim LM, Chang JM, Wang IF, et al. Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient[J]. BMC Pediatr, 2013,13:150.
[13] Garbett ND, Currie DC, Cole PJ. Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia[J]. Clin and Exp Immunol, 1989,76: 1-7.
[14] Kerr J, Quinti I, Eibl M, et al. Is dosing of therapeutic immunoglobulins optimal? a review of a three-decade long debate in europe[J]. Front Immunol, 2014,5: 629.

编辑推荐

Metrics

阅读次数

全文

214

HTML			PDF

最新录用	在线预览	正式出版	最新录用	在线预览	正式出版
0	0	0	0	0	214

来源	本网站	其他网站

次数	196	18
比例	92%	8%

摘要

一例X-连锁无丙种球蛋白血症患者BTK基因新变异体的鉴定

Identification of a novel BTK variant in a Chinese family with X-linked agammaglobulinemia

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	郑海霞, 周王继, 田欣伦, 刘雅萍. 2例中国原发性纤毛运动障碍患者致病变异的鉴定[J]. 基础医学与临床, 2024, 44(5): 677-682.
[2]	刘思邑, 杨玉姣, 杨涛, 赵秀丽. 结节性硬化症5个家系致病变异的鉴定[J]. 基础医学与临床, 2024, 44(3): 361-367.